[1] McCarthy J, Yang J, Clissold B, et al. Hypertension management in stroke prevention: time to consider primary aldosteronism[J]. Stroke, 2021, 52(10): e626-e634. [2] Turana Y, Tengkawan J, Chia YC, et al.Hypertension and stroke in Asia: A comprehensive review from HOPE Asia[J]. J Clin Hypertens (Greenwich), 2021, 23(3): 513-521. [3] Tu WJ, Wang LD, Special Writing Group of China Stroke Surveillance Report. China stroke surveillance report 2021[J]. Mil Med Res, 2023, 10(1): 33. [4] Hao G, Chen Z, Wang X, et al.Evaluation of the community-based hypertension management programs in China[J]. Front Public Health, 2022, 10: 896603. [5] 《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2021》概述[J]. 中国心血管病研究,2022,20(7):577-596. [6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志,2022,55(10):1071-1110. [7] 中国高血压防治指南修订委员会,高血压联盟(中国),中国医疗保健国际交流促进会高血压分会,等. 中国高血压防治指南(2024年修订版)[J]. 中华高血压杂志,2024,32(7):603-700. [8] Zhang M, Guo L, Namassevayam G, et al.Factors associated with health behaviours among stroke survivors: A mixed-methods study using COM-B model[J]. J Clin Nurs, 2024, 33(6): 2138-2152. [9] Ma S, Yang L, Zhao M, et al.Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991-2015[J]. J Hypertens, 2021, 39(4): 740-748. [10] Lee SR, Park C, Choi E, et al.Hypertension burden and the risk of new-onset atrial fibrillation: A nationwide population based study[J]. Hypertension, 2021, 77(3): 919-928. [11] 张梅,吴静,张笑,等. 2018年中国成年居民高血压患病与控制状况研究[J]. 中华流行病学杂志,2021,42(10):1780-1789. [12] 曾望远,周素云,顾申红. 海口市社区高血压现状调查及全科干预效果研究[J]. 中国全科医学,2020,23(18):2335-2341. [13] Feigin VL, Owolabi MO, World Stroke Organization-Lancet Neurology Commission Stroke Collaboration Group. Pragmatic solutions to reduce the global burden of stroke: A World Stroke Organization-Lancet Neurology Commission[J]. Lancet Neurol, 2023, 22(12): 1160-1206. [14] Boos CJ, Toon LT, Almahdi H.The relationship between ambulatory arterial stiffness, inflammation, blood pressure dipping and cardiovascular outcomes[J]. BMC Cardiovasc Disord, 2021, 21(1): 139. [15] Furie K.Epidemiology and primary prevention of stroke[J]. Continuum (Minneap Minn), 2020, 26(2): 260-267. [16] 刘克军,陈伟伟. 动态血压监测应用于社区高血压诊断的卫生经济学评价[J]. 中国药物经济学,2020,15(11):25-28. [17] Alhowaymel FM, Abdelmalik MA, Mohammed AM, et al.Knowledge, attitudes, and practices of hypertensive patients towards stroke prevention among rural population in Saudi Arabia: A cross-sectional study[J]. SAGE Open Nurs, 2023, 9: 23779608221150717. [18] 宋利英,杨柳,姚尼娜,等. 以社会综合支持为基础的护理干预对社区高血压患者的影响[J]. 齐鲁护理杂志,2022,28(17):140-142. [19] Tian Z, Vollmer Barbosa C, Lang H, et al.Efficacy of pharmacological and interventional treatment for resistant hypertension: A network meta-analysis[J]. Cardiovasc Res, 2024, 120(1): 108-119. [20] 施艳,袁莉,白雅,等. 远程管理模式在脑卒中并发高血压患者中的应用[J]. 山西医药杂志,2021,50(7):1065-1067. [21] 严雪雯. 综合护理干预模式在高血压缺血性脑卒中患者的应用效果及患者血压改善情况[J]. 中国药物与临床,2020,20(4):663-665. |